| Phosmet | Experimental Vet Approved | IL13 | 3596 |
upregulated | Phosmet results in increased expression of IL13 mRNA | 5q31.1 | |
| Phosmet | Experimental Vet Approved | IL17A | 3605 |
upregulated | Phosmet results in increased expression of IL17A mRNA | 6p12.2 | |
| N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium | Investigational | MMP1 | 4312 |
upregulated | Phosphorylcholine analog results in increased expression of MMP1 mRNA | 11q22.2 | |
| N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium | Investigational | TIMP1 | 7076 |
upregulated | Phosphorylcholine analog results in increased expression of TIMP1 mRNA | Xp11.3 | |
| N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium | Investigational | TNF | 7124 |
upregulated | Phosphorylcholine analog results in increased expression of TNF mRNA | 6p21.33 | |
| Phthalic Acid | Experimental | CYP3A4 | 1576 |
upregulated | phthalic acid results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Pimozide | Approved | BCL2 | 596 |
downregulated | Pimozide results in decreased expression of BCL2 mRNA | 18q21.33 | |
| Pioglitazone | Approved Investigational | ABCA1 | 19 |
upregulated | pioglitazone results in increased expression of ABCA1 mRNA | 9q31.1 | |
| Pioglitazone | Approved Investigational | ACAT1 | 38 |
downregulated | pioglitazone results in decreased expression of ACAT1 mRNA | 11q22.3 | |
| Pioglitazone | Approved Investigational | ATP5B | 506 |
downregulated | pioglitazone results in decreased expression of ATP5B mRNA | 12q13.3 | |
| Pioglitazone | Approved Investigational | BACE1 | 23621 |
downregulated | pioglitazone results in decreased expression of BACE1 mRNA | 11q23.3 | |
| Pioglitazone | Approved Investigational | CD36 | 948 |
upregulated | pioglitazone results in increased expression of CD36 mRNA | 7q21.11 | |
| Pioglitazone | Approved Investigational | CES1 | 1066 |
upregulated | pioglitazone results in increased expression of CES1 mRNA | 16q12.2 | |
| Pioglitazone | Approved Investigational | CYBA | 1535 |
downregulated | pioglitazone results in decreased expression of CYBA mRNA | 16q24.2 | |
| Pioglitazone | Approved Investigational | CYP17A1 | 1586 |
downregulated | pioglitazone results in decreased expression of CYP17A1 mRNA | 10q24.32 | |
| Pioglitazone | Approved Investigational | CYP3A4 | 1576 |
upregulated | pioglitazone results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Pioglitazone | Approved Investigational | FABP4 | 2167 |
upregulated | pioglitazone results in increased expression of FABP4 mRNA | 8q21.13 | |
| Pioglitazone | Approved Investigational | FGF21 | 26291 |
upregulated | pioglitazone results in increased expression of FGF21 mRNA | 19q13.33 | |
| Pioglitazone | Approved Investigational | HMGCR | 3156 |
upregulated | pioglitazone results in increased expression of HMGCR mRNA | 5q13.3 | |
| Pioglitazone | Approved Investigational | HMGCS1 | 3157 |
upregulated | pioglitazone results in increased expression of HMGCS1 mRNA | 5p12 | |
| Pioglitazone | Approved Investigational | HSD3B2 | 3284 |
downregulated | pioglitazone results in decreased expression of HSD3B2 mRNA | 1p12 | |
| Pioglitazone | Approved Investigational | NPHS1 | 4868 |
upregulated | pioglitazone results in increased expression of NPHS1 mRNA | 19q13.12 | |
| Pioglitazone | Approved Investigational | NR1H2 | 7376 |
upregulated | pioglitazone results in increased expression of NR1H2 mRNA | 19q13.3 | |
| Pioglitazone | Approved Investigational | NR1H3 | 10062 |
upregulated | pioglitazone results in increased expression of NR1H3 mRNA | 11p11.2 | |
| Pioglitazone | Approved Investigational | PCSK9 | 255738 |
upregulated | pioglitazone results in increased expression of PCSK9 mRNA | 1p32.3 | |